3029 |
Scaffolds in Complex LM Lesions |
Marie-Claude Morice |
Apr. 21. 16 |
3028 |
Left Main PCI in Acute MI |
Michael S. Lee |
Apr. 21. 16 |
3027 |
Intervention of LMCA Bifurcation: Is It Different in 2016? |
Debabrata Dash |
Apr. 21. 16 |
3026 |
Extremely High Risk for TAVR - Insights from QOL and Cost-Effectiveness Studies |
David Joel Cohen |
Apr. 21. 16 |
3025 |
TAVR for Bicuspid AS |
Sung Han Yoon |
Apr. 21. 16 |
3024 |
Valve Thrombosis/Leaflet Thickening: To Treat or Not to Treat |
Raj Makkar |
Apr. 21. 16 |
3023 |
Paravalvular Regurgitation After TAVR: Insights from PARTNER II S3HR and S3i |
Susheel Kodali |
Apr. 21. 16 |
3022 |
Inferior Role of OMT Versus PCI |
Richard R. Heuser |
Apr. 21. 16 |
3021 |
Comparable Impact of OMT After Failed Versus Successful CTO-PCI |
Seung-Whan Lee |
Apr. 21. 16 |
3020 |
Wrap-up CTO Techniques/Devices to Improve Success in CTO-PCI |
Dimitrios Karmpaliotis |
Apr. 21. 16 |